Anträge auf klinische Prüfungen gemäß § 41c des Arzneimittelgesetzes

This procedure involves a written question to the German government regarding the application process for clinical trials as specified in Section 41c of the Medicines Act. It seeks to clarify how these medical trials are approved and monitored to ensure patient safety and legal compliance. The procedure affects pharmaceutical companies, medical researchers, and healthcare providers involved in testing new medicines within Germany.